The SPDR S&P Biotech ETF (XBI ), one of the largest biotechnology exchange traded funds (ETFs), is up more than 24% this year, indicating the biotech space remains in favor as investors look for avenues to access innovative concepts and themes.
Biotech ETFs: Destinations For Investing in Innovation
previous post